What this study is
This study will evaluate a program called On Track for Wellness (OTW) which is being adopted by the Illinois Department of Human Services' Division of Behavioral Health \& Recovery (DBHR) for use in all state-funded early psychosis programs in Illinois. OTW combines use of Fitbit activity trackers with health education, goal setting to promote health activation, and ongoing support for maintaining healthy lifestyles. Successful completion of this research will gauge the effectiveness of this program in improving sleep hygiene and increasing physical activity among people recently diagnosed with schizophrenia or other psychotic disorders.
What's being tested
- On Track for Wellness
Intervention · OTHER
Client education regarding sleep and physical activity accompanied by use of a Fitbit tracker
Study details
- Official title
- On Track for Wellness: Stepped-wedge Cluster Randomized Trial of a Fitbit Enhanced Health Intervention for Early Onset Psychosis
- Sponsor
- University of Illinois at Chicago
- Conditions
- Sleep · Physical Activity · First Episode Psychosis
- Enrolling
- 365 people
- Starts
- 2026-09-01
- Est. completion
- 2030-12-01
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Client at First Episode psychosis program funded by the Illinois Department of Human Services. Enrollment is at program level; no individual subject enrollment.
You can't join if
- Not a client at a First Episode psychosis program funded by the Illinois Department of Human Services. Enrollment is at program level; no individual subject enrollment.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Illinois Chicago
Chicago, Illinois, United States
Recruiting
Study team
Sponsor
University of Illinois at Chicago
Study ID STUDY2025-1399
Principal investigator
Judith A Cook, Ph.D
University of Illinois at Chicago
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.